Venture
fromBusiness Matters
4 days agoBritish Business Bank backs NRG Therapeutics with 8m investment in 50m Series B round
British Business Bank invested £8 million in NRG Therapeutics to develop mPTP inhibitors targeting mitochondrial dysfunction in ALS and Parkinson's.